GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (œRevolo or the œCompany), a company developing therapies that reset the immune system to...
- New preclinical data further elucidate ˜1805™s mechanism of action in rheumatoid arthritis (RA) - NEW ORLEANS and CAMBRIDGE, United Kingdom, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Revolo...
#NAME?
NEW ORLEANS and CAMBRIDGE, United Kingdom, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (œRevolo or the œCompany), a company developing therapies that reset the immune system to...
NEW ORLEANS and CAMBRIDGE, United Kingdom, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (œRevolo or the œCompany), a company developing therapies that reset the immune system to...
NEW ORLEANS and CAMBRIDGE, United Kingdom, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (œRevolo or the œCompany), a company developing therapies that reset the immune system to...
Revolo Biotherapeutics Announces Additional Data from Phase 2a Trial of €˜1104 in Adults with Active Eosinophilic Esophagitis
NEW ORLEANS and CAMBRIDGE, United Kingdom, June 05, 2023 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (œRevolo or the œCompany), a company developing therapies that reset the immune system to...
Data continues to demonstrate the broader potential of ‘1104 to avoid and reduce inflammation in multiple models of disease, including allergy and beyond NEW ORLEANS and CAMBRIDGE, UK,, May 22, 2023...
NEW ORLEANS and CAMBRIDGE, United Kingdom, May 10, 2023 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (âœRevolo❠or the âœCompanyâ), a company developing therapies that reset the immune system to achieve...